Levocarnitine and Fosamax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levocarnitine (levocarnitine) and Fosamax (alendronate sodium). Common drug interactions include pancreatic insufficiency among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Levocarnitine and Fosamax. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

What is Fosamax?

Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,452 Fosamax users. Check the latest studies of Fosamax.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 18, 2026

13 people who take Levocarnitine and Fosamax together, and have interactions are studied.

Levocarnitine and Fosamax drug interactions.

What are the common drug interactions of Levocarnitine and Fosamax, by gender? *:

female:

Pancreatic insufficiency
Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles)
Salivary gland calculus (stone in salivary gland)
Sedation
Sialoadenitis (inflammation of a salivary gland)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Somnolence (a state of near-sleep, a strong desire for sleep)
Speech disorder
Venous insufficiency (poor circulation of blood caused by damaged or enlarged veins)
Vision blurred

male:

Pyrexia (fever)
Acute myocardial infarction (acute heart attack)
Infusion related reaction
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Malaise (a feeling of general discomfort or uneasiness)
Mucosal discolouration (change in colour of mucosal membrane)
Nausea (feeling of having an urge to vomit)
Nipple pain
Parainfluenzae virus infection
Pneumonia

What are the common drug interactions of Levocarnitine and Fosamax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Dehydration (dryness resulting from the removal of water)
Ear infection
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Vomiting

10-19:

Crying
Discomfort
Drug intolerance (drug sensitivity)
Emotional disorder
Fatigue (feeling of tiredness)
Mucosal discolouration (change in colour of mucosal membrane)
Parainfluenzae virus infection
Pyrexia (fever)
Respiratory distress (difficulty in breathing)
Respiratory tract infection viral

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Acute myocardial infarction (acute heart attack)
Blood pressure decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Cough
Fatigue (feeling of tiredness)
Heat exhaustion (dizziness and nausea and weakness caused by depletion of body fluids and electrolytes)
Infected cyst
Influenza
Infusion related reaction

60+:

Anaemia postoperative
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Dyspnoea exertional (breathlessness or shortness of breath)
Epidural fibrosis
Fall
Femur fracture
Foot fracture
Gait disturbance
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Headache (pain in head)

What are the existing conditions these people have? *

Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 23.08%
Cystinosis (abnormal accumulation of the amino acid cystine): 3 people, 23.08%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.69%
Spinal Osteoarthritis (joint cartilage loss in spine): 1 person, 7.69%
Seizure Cluster (small group of seizure): 1 person, 7.69%
Seasonal Allergy (allergic condition due to certain season): 1 person, 7.69%
Pain: 1 person, 7.69%
Neuropathy Peripheral (surface nerve damage): 1 person, 7.69%
Mitochondrial Enzyme Deficiency (lack of mitrocondrial enzyme): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and Fosamax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously